![Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males](https://www.g2intelligence.com/wp-content/uploads/2024/01/Feb24.LIA_.DXDEALS.RS-iStock-1100x800-1-1080x675.jpg)
Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Labs, patients, and technology must all work together to deliver forward-thinking patient-centered care.
Genialis CEO and co-founder Rafael Rosengarten, PhD, discusses key 2023 AI developments and what they could mean for laboratories.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?